Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-21
2011-10-25
Qazi, Sabiha (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S139000, C548S240000, C549S430000
Reexamination Certificate
active
08044080
ABSTRACT:
The present invention relates to an isoxazoline derivative having the cyclic carboxylic acid hemiketal moiety of formula (1) for use as caspase inhibitor, a process for preparing it, and a pharmaceutical composition comprising it.
REFERENCES:
patent: 1999-79267 (1999-11-01), None
patent: WO-01/21599 (2001-03-01), None
patent: WO-01/21600 (2001-03-01), None
patent: WO-2005/021516 (2005-03-01), None
Lewis Acid Coordinated Nitrile Oxide and Nitrile Imine 1,3-Dipoles. syn-Selective Cycloadditions to 2-(1-Hydroxyalkyl)acrylates, Bull. Chem. Soc. Jpn., vol. 66, pp. 2685-2693.
Synthesis of a Peptidyl Difluoro Ketone Bearing the Aspartic Acid Side Chain: An Inhibitor of Interleukin-1beta Convering Enzyme, J. Org. Chem., vol. 57, pp. 7309-7314.
Choi Hyeong Wook
Heo Tae Ho
Lee Jae Hoon
Lee Kyu Woong
Park Ki Sook
Birch & Stewart Kolasch & Birch, LLP
LG Life Sciences Ltd.
Qazi Sabiha
LandOfFree
Isoxazoline derivative and novel process for its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazoline derivative and novel process for its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazoline derivative and novel process for its preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4260983